
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 August 11
🇺🇸 United States – Remote
💵 $275k - $300k / year
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 16%
Where this job comes from
Posted on Kyverna Therapeutics's careers page ↗, not through a job board
First seen by Remote Rocketship August 11
Still open on Kyverna Therapeutics's site. Checked 7 hours ago.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Lead the Medical Writing function, including its strategic direction, operating model, and capabilities • Develop departmental goals and operational priorities aligned with organizational and Regulatory Affairs objectives • Represent Medical Writing on cross-functional governance and program teams • Build a high-performing organization supporting clinical development, regulatory submissions, and commercialization • Oversee planning, development, review, and delivery of complex regulatory and scientific documents across the product lifecycle • Develop integrated document strategies supporting global submission objectives • Provide scientific and regulatory guidance on content development, messaging, and submission readiness • Ensure documents meet regulatory requirements and company quality standards • Partner with senior leaders to identify documentation needs and execution risks • Influence submission strategy, resource requirements, timelines, and regulatory deliverables • Resolve complex issues affecting documentation quality, timelines, or submission readiness • Represent Medical Writing during regulatory inspections, due diligence activities, and partner interactions • Recruit, develop, and retain a high-performing Medical Writing organization • Establish organizational structure, workforce planning, and succession strategies • Coach and develop functional leaders • Develop departmental processes, standards, templates, metrics, and governance • Lead resource planning and capacity management across internal staff and external partners • Oversee departmental budget planning and vendor strategy • Drive continuous improvement in quality, efficiency, scalability, and regulatory compliance
• Advanced degree in life sciences, pharmacy, medicine, or a related discipline preferred (PhD, PharmD, MD, or equivalent) • 12+ years of progressive medical writing experience in the biotechnology or pharmaceutical industry • Significant leadership experience • Demonstrated success leading Medical Writing organizations supporting global clinical development and regulatory submissions • Deep understanding of FDA, EMA, and ICH regulatory requirements and guidance across the product lifecycle • Experience supporting INDs, BLAs, MAAs, and lifecycle management activities • Ability to influence cross-functional decision-making and build collaborative relationships across senior leadership teams • Experience developing organizational capabilities, leading organizational change, and scaling teams within a growing company • Strong executive communication, leadership, and interpersonal skills • Ability to manage multiple complex programs while balancing strategic priorities with operational execution • West Coast hours preferred for remote work
• Bonus eligibility • Benefits • Participation in Company’s stock plan
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 August 11
Medical Director leading physicians and advanced practice providers for Nourish, an AI-native metabolic health clinic. Scaling clinical quality, interdisciplinary care, and digital healthcare delivery.
🕒 August 10
Clinical pharmacy director driving Medicare Advantage and Part D Stars performance at Devoted Health. Forecasting quality measures, guiding interventions, and leading cross-functional execution.
🕒 August 7
Senior Director leading clinical pharmacology strategy for Amylyx Pharmaceuticals’ PBH, Wolfram syndrome, and ALS drug programs. Guiding PK/PD, modeling, trials, and regulatory submissions.
🕒 July 31
Chief Medical Officer at Artera, responsible for setting medical vision and clinical strategy in AI-driven cancer therapy. Leading collaborations and guiding innovations to impact cancer treatment.
🕒 July 31
Executive Medical Director responsible for global product safety strategy and pharmacovigilance activities. Leading safety analyses and cross-functional collaborations for oncology biotech products.
🇺🇸 United States – Remote
💵 $355k - $504k / year
💰 $65M Post-IPO Equity on 2012-02
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🦅 H1B Visa Sponsor